ES2061607T3 - Capsula de liberacion oral instantanea, con contenido de nifedipina. - Google Patents

Capsula de liberacion oral instantanea, con contenido de nifedipina.

Info

Publication number
ES2061607T3
ES2061607T3 ES88118596T ES88118596T ES2061607T3 ES 2061607 T3 ES2061607 T3 ES 2061607T3 ES 88118596 T ES88118596 T ES 88118596T ES 88118596 T ES88118596 T ES 88118596T ES 2061607 T3 ES2061607 T3 ES 2061607T3
Authority
ES
Spain
Prior art keywords
solution
nifedipine
release capsule
instant oral
oral release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88118596T
Other languages
English (en)
Inventor
Walter Wimmer
Miller Ronald Brown
Mortimer David Sackler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6340247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2061607(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of ES2061607T3 publication Critical patent/ES2061607T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

LA INVENCION CONCIERNE A UNA CAPSULA DE LIBERACION ORAL INSTANTANEA QUE CONTIENE UNA SOLUCION ACUOSA O HIDRO - ALCOHOLICA DE NIFEDIPINA QUE CONTIENE UN POLIALQUILEN GLICOL Y UN COMPONENTE DE ESTER DE POLIOXIETILENO, SIENDO LA CANTIDAD DE ESTER SUFICIENTE PARA PREVENIR LA PRECIPITACION DE NIFEDIPINA EN LA BOCA DE UN PACIENTE DESPUES DE LA LIBERACION DE LA SOLUCION DE LA CAPSULA. PREFERIBLEMENTE EL COMPONENTE ESTER ES UN ACEITE DE RICINO HIDROGENADO ETOXILADO CREMOPHOR RH40. LA SOLUCION PUEDE CONTENER UN SEGUNDO COMPONENTE GLICOL, ESPECIALMENTE GLICEROL.
ES88118596T 1987-11-11 1988-11-09 Capsula de liberacion oral instantanea, con contenido de nifedipina. Expired - Lifetime ES2061607T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873738236 DE3738236A1 (de) 1987-11-11 1987-11-11 Beisskapsel

Publications (1)

Publication Number Publication Date
ES2061607T3 true ES2061607T3 (es) 1994-12-16

Family

ID=6340247

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88118596T Expired - Lifetime ES2061607T3 (es) 1987-11-11 1988-11-09 Capsula de liberacion oral instantanea, con contenido de nifedipina.

Country Status (10)

Country Link
US (1) US5200192A (es)
EP (1) EP0315960B1 (es)
JP (1) JPH01238528A (es)
AT (1) ATE101516T1 (es)
AU (1) AU616693B2 (es)
CA (1) CA1312549C (es)
DE (2) DE3738236A1 (es)
ES (1) ES2061607T3 (es)
IE (1) IE63182B1 (es)
ZA (1) ZA888441B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
IT1263840B (it) * 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
ES2234010T3 (es) * 1996-04-12 2005-06-16 Novadel Pharma Inc. Aerosol bucal polar.
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
EP1952802A3 (en) 1997-10-01 2009-06-17 Novadel Pharma Inc. Buccal, polar and non-polar spray or capsule
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US6168806B1 (en) 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
DE19922537A1 (de) * 1999-05-10 2000-11-16 Roland Bodmeier Darreichungsform zur Applikation in Körperöffnungen
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
SE9902742D0 (sv) * 1999-07-20 1999-07-20 Astra Ab New pharmaceutical formultion
AU2001270891A1 (en) * 2000-08-17 2002-03-04 Machines Industrielles Etablissements Consumable container
US20030003144A1 (en) * 2001-05-01 2003-01-02 Keller Brian C. Sustained release formulations for nifedipine, dextromethorphan, and danazol
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
CA2563533C (en) 2004-04-15 2013-10-01 Shmuel A. Ben-Sasson Compositions capable of facilitating penetration across a biological barrier
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
US7530804B2 (en) * 2004-12-07 2009-05-12 Mcneil-Ppc, Inc. System and process for providing at least one opening in dosage forms
WO2009091622A1 (en) * 2008-01-18 2009-07-23 Dow Global Technologies Inc. Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol
KR101814186B1 (ko) 2008-09-17 2018-03-14 키아스마 인코포레이티드 약제학적 조성물 및 연관된 투여방법
BR112013031406B1 (pt) * 2011-06-08 2022-02-22 Lts Lohmann Therapie-Systeme Ag Tira de filme oral comestível e seu método de preparação
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU432703A3 (es) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
DE2209526C3 (de) * 1972-02-29 1980-02-28 Bayer Ag, 5090 Leverkusen Coronartherapeutlkum in Form von Gelatine-BeiBkapseln
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
DE3437599C2 (de) * 1984-10-13 1987-04-16 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende Weichgelatinekapseln
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
EP0272336B1 (de) * 1986-12-18 1991-10-23 Kurt H. Prof. Dr. Bauer Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
JPH01238528A (ja) 1989-09-22
AU616693B2 (en) 1991-11-07
AU2499388A (en) 1989-05-11
US5200192A (en) 1993-04-06
IE63182B1 (en) 1995-03-22
CA1312549C (en) 1993-01-12
ZA888441B (en) 1989-08-30
DE3738236A1 (de) 1989-05-24
EP0315960B1 (en) 1994-02-16
EP0315960A1 (en) 1989-05-17
IE883378L (en) 1989-05-11
ATE101516T1 (de) 1994-03-15
DE3887826T2 (de) 1994-09-22
DE3887826D1 (de) 1994-03-24

Similar Documents

Publication Publication Date Title
ES2061607T3 (es) Capsula de liberacion oral instantanea, con contenido de nifedipina.
ES2120516T3 (es) Preparacion de composiciones farmaceuticas que contienen una calcitonina.
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
DE3379496D1 (en) Constant release rate solid oral dosage formulations of cardiovascular drugs
IE882442L (en) Administration of implants
GR3004448T3 (es)
DE69105040D1 (de) Arzneimittel gegen Impotenz.
IE812354L (en) Prostaglandin capsule
PH25286A (en) Sustained release drug preparation
IE893718L (en) Pharmaceutical Compositions
IL86395A0 (en) Pharmaceutical compositions containing flunarizine
DK0657164T3 (da) Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid
MX9703480A (es) Composiciones inmunogenicas.
FR2618670B1 (fr) Preparation medicamenteuse a base d'huiles essentielles, ainsi que pate dentaire et gomme a macher la contenant
AU2072088A (en) Agent containing salicylic acid for treating lepidosis
DE3870154D1 (de) Phenol enthaltende, fluessige antitussiv-zusammensetzungen.
KR900014382A (ko) (s)-7-(3-아미노-1-피롤리디닐)-1-시클로프로필-6-플루오로-1,4-디히드로-4-옥소-나프티리딘-3-카르복실산
SG49770A1 (en) Pharmaceutical preparation
ATE116547T1 (de) Alginsäure enthaltende arzneisuspension.
ES2031922T3 (es) Composiciones terapeuticas estables a base de aceite vegetal hidrofobo y su procedimiento de preparacion.
JPS56166108A (en) Base for cosmetic and medicine
NZ218898A (en) Disinfecting compositions containing glutaraldehyde and conjugated aldehydes
GR860962B (en) Tobacco compositions method and device for releasing essentially pure nicotine

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 315960

Country of ref document: ES